IDEXX Laboratories Inc. (IDXX)

IDEXX Laboratories Inc. (IDXX $591.84)
- $591.84 P/E (TTM): 44.15X Cap: $45.70B
- View IDXX Profile
- View Questions on IDXX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $462.28)
- $462.28 P/E (TTM): 57.51X Cap: $160.85B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $443.92)
- $443.92 P/E (TTM): 28.4X Cap: $112.95B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $211.59)
- $211.59 P/E (TTM): 87.58X Cap: $365.01B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $241.30)
- $241.30 P/E (TTM): 21.85X Cap: $581.19B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $953.30)
- $953.30 P/E (TTM): 40.39X Cap: $900.69B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $123.18)
- $123.18 P/E (TTM): 16.6X Cap: $304.54B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $171.86)
- $171.86 P/E (TTM): 20.63X Cap: $8.13B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $591.84)
- $591.84 P/E (TTM): 44.15X Cap: $45.70B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $65.43)
- $65.43 P/E (TTM): 24.93X Cap: $7.53B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $95.89)
- $95.89 P/E (TTM): 14.8X Cap: $18.64B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $25.31)
- $25.31 P/E (TTM): 14.78X Cap: $3.09B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.26)
- $28.26 P/E (TTM): 368.76X Cap: $237.13B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Adobe Inc. (ADBE $239.31)
- $239.31 P/E (TTM): 14.24X Cap: $97.06B
- View ADBE Profile
- View Questions on ADBE
Accenture plc Class A (Ireland) (ACN $193.84)
- $193.84 P/E (TTM): 16.44X Cap: $131.23B
- View ACN Profile
- View Questions on ACN
Nike Inc. (NKE $43.13)
- $43.13 P/E (TTM): 29.16X Cap: $63.87B
- View NKE Profile
- View Questions on NKE
Thermo Fisher Scientific Inc (TMO $503.46)
- $503.46 P/E (TTM): 27.52X Cap: $181.84B
- View TMO Profile
- View Questions on TMO
TELUS Corporation (T $17.47)
- $17.47 P/E (TTM): 24.86X Cap: $26.74B
- View T Profile
- View Questions on T
IDEXX Laboratories Inc. (IDXX $591.84)
- $591.84 P/E (TTM): 44.15X Cap: $45.70B
- View IDXX Profile
- View Questions on IDXX

Q: Dear 5i,

I have a diverse portfolio with stocks and ETFs. Most of my portfolio is doing well. Want to know your thoughts about a few of my holdings that are not doing so well - Adobe, Nike, Accenture, TMO, IDXX and Telus.

What are your thoughts? Should I replace these with a US ETF or hold on. Thanks for your valuable advice as always.

Read Answer Asked by Alka on November 26, 2025

IDEXX Laboratories Inc. (IDXX $591.84)
- $591.84 P/E (TTM): 44.15X Cap: $45.70B
- View IDXX Profile
- View Questions on IDXX

Q: I bought half a position in IDEXX about a month ago, they recently had about a 25% pop after their results. Would you be comfortable for me adding to my position here?

Read Answer Asked by Andrew on August 11, 2025